Introduction. An open fracture refers to a break in the skin, which is exposed to microbial contamination and eventually leads to most complicated infections. X-rays can kill bacteria by causing irreversible DNA damage. Objective. To confirm the role of X-ray exposure in treating infected wound fractures at the lower limb and determine X-ray exposure times. Methods. Fifty-one wound swabs were collected from patients with infected open fractures at the lower limb with grade II, IIIA, B, and C according to the Gustilo and Anderson classification system and then cultured. e bacterial isolates were identified by biochemical tests and the VITEK-2 System and tested against several antibiotics. e X-ray exposure was done for open fractures by radiography (at kV133 and 5 milliambers). Results. e higher isolation rate was recorded for Staphylococcus aureus with 21 (41.2%) isolates, and most of them (20, 95.2%) were isolated from grade II fractures. e isolation rate of Gram-negative bacteria was 25.5% for Escherichia coli with 13 isolates, 19.6% for Pseudomonas aeruginosa with 10 isolates, and 13.7% for Klebsiella pneumoniae with 7 isolates, most of which were isolated from grade III fractures. e isolation rate of P. aeruginosa was 60% (6 isolates) from grade IIIA and 71.4% (5 isolates) from grade IIIB for K. pneumoniae, while for E. coli it was 69.2% (9 isolates) from grade IIIC. All the bacterial isolates recorded high levels of antibiotic resistance against most tested antibiotics. Wound cultures of grade II fractures appeared sterile after the first X-ray exposure, and these wounds were infected with S. aureus or P. aeruginosa. However, cultures of grade IIIA and IIIB fractures appeared sterile after the second X-ray exposure for all isolated bacteria, except for S. aureus (grade IIIA fractures) (after the third X-ray exposure). Grade IIIC fractures showed sterile culture after the third X-ray exposure for wounds infected with P. aeruginosa and E. coli. Conclusions. e study concluded that X-ray exposure showed high effectiveness in treating infected open fractures.
Introduction: Staphylococci emerged as the most frequent nosocomial and community-acquired pathogens. Macrolide-lincosamide-streptogramin (MLS) antibiotics resistance was increasing among Staphylococcus aureus and Staphylococcus epidermidis (S. epidermidis) isolates. Objective: In the present study, the aim was to detect the phenotypic resistance pattern of MLS (constitutive and inducible) among S. aureus and S. epidermidis isolated from Iraqi patients. Methods: A total of 120 staphylococcal isolates (60 S. aureus and 60 S. epidermidis) were isolated from urine, wound swab, blood, and sputum specimens, then specified by the VITEK 2 system. Whole isolates were investigated by the disk-diffusion method against many antibiotics, then they were checked for the MLS phenotype by the D-zone test. Results: Out of 60 S. aureus isolates and 60 S. epidermidis, the isolation rates from wound, urine, blood, and sputum were 66.6 and 50%, 16.7 and 26.7%, 11.7 and 18.3%, and 5% for each species, respectively. The higher frequency rates of resistance were showed against erythromycin, clindamycin, and streptomycin, for both S. aureus with 83.3, 53.3, and 83.3%, respectively, and S. epidermidis with 73.3, 45, and 76.7%, respectively. Constitutive MLS resistance phenotype (MLSc) was shown in 32 isolates (53.3%) of S. aureus and inducible MLS resistance phenotype (MLSi) was noted in 16 isolates (26.7%). Conclusion: The current study concluded that the D-zone test must be applied within the routine work of the antimicrobial susceptibility test for staphylococcal isolates, to exclude the false results of staphylococcal isolates sensitivity against clindamycin.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.